Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta

Bone

Volumn 47, Issue 3, 2010, Pages 546-555

  Li, Feng ^a   Wang, Xujun ^a   Niyibizi, Christopher ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Bone repair; Bone stromal marrow cells; Cell transplantation; Collagen; Osteogenesis imperfecta

Indexed keywords

COLLAGEN TYPE 1; OSTEOCALCIN; PEPSIN A; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MARROW CELL; CELL DIFFERENTIATION; CELL SUSPENSION; CELL TRANSPLANTATION; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMUR; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOGENESIS IMPERFECTA; PROTEIN EXPRESSION; STROMA CELL;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMUR; HUMANS; MICE; OSTEOCALCIN; OSTEOGENESIS; OSTEOGENESIS IMPERFECTA; STROMAL CELLS;

EID: 77955841273     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.05.040     Document Type: Article

References (45)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
2. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295.
3. Dreyfus P.A., Chretien F., Chazaud B., Kirova Y., Caramelle P., Garcia L., et al. Adult bone marrow-derived stem cells in muscle connective tissue and satellite cell niches. Am J Pathol 2004, 164:773-779.
4. Bi Y., Ehirchiou D., Kilts T.M., Inkson C.A., Embree M.C., Sonoyama W., et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007, 13:1219-1227.
5. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
6. Caplan A.I. Why are MSCs therapeutic? New data: new insight. J Pathol 2009, 217:318-324.
7. Mankani M.H., Kuznetsov S.A., Marshall G.W., Robey P.G. Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng A 2008, 14:1949-1958.
8. Arthur A., Zannettino A., Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 2009, 218:237-245.
9. Wang C., Wang Z., Li A., Bai F., Lu J., Xu S., et al. Repair of segmental bone-defect of goat's tibia using a dynamic perfusion culture tissue engineering bone. J Biomed Mater Res A 2009.
10. Tan M.Y., Zhi W., Wei R.Q., Huang Y.C., Zhou K.P., Tan B., et al. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 2009.
11. Li F., Wang X., Niyibizi C. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Stem Cells 2007, 25:3183-3193.
12. Mankani M.H., Kuznetsov S.A., Wolfe R.M., Marshall G.W., Robey P.G. In vivo bone formation by human bone marrow stromal cells: reconstruction of the mouse calvarium and mandible. Stem Cells 2006, 24:2140-2149.
13. Haider H., Jiang S., Idris N.M., Ashraf M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 2008, 103:1300-1308.
14. Lee S.Y., Nakagawa T., Reddi A.H. Induction of chondrogenesis and expression of superficial zone protein (SZP)/lubricin by mesenchymal progenitors in the infrapatellar fat pad of the knee joint treated with TGF-beta1 and BMP-7. Biochem Biophys Res Commun 2008, 376:148-153.
15. Zachos T., Diggs A., Weisbrode S., Bartlett J., Bertone A. Mesenchymal stem cell-mediated gene delivery of bone morphogenetic protein-2 in an articular fracture model. Mol Ther 2007, 15:1543-1550.
16. Peterson B., Zhang J., Iglesias R., Kabo M., Hedrick M., Benhaim P., et al. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 2005, 11:120-129.
17. Pereira R.F., O'Hara M.D., Laptev A.V., Halford K.W., Pollard M.D., Class R., et al. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A 1998, 95:1142-1147.
18. Wang X., Li F., Niyibizi C. Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases. Stem Cells 2006, 24:1869-1878.
19. Niyibizi C., Wang S., Mi Z., Robbins P.D. The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells. Mol Ther 2004, 9:955-963.
20. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002, 99:8932-8937.
21. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., Koo W.W., Gordon P.L., Neel M., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999, 5:309-313.
22. Horwitz E.M., Prockop D.J., Gordon P.L., Koo W.W., Fitzpatrick L.A., Neel M.D., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001, 97:1227-1231.
23. Guillot P.V., Abass O., Bassett J.H., Shefelbine S.J., Bou-Gharios G., Chan J., et al. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 2008, 111:1717-1725.
24. Wang L., Liu Y., Kalajzic Z., Jiang X., Rowe D.W. Heterogeneity of engrafted bone-lining cells after systemic and local transplantation. Blood 2005, 106:3650-3657.
25. Anjos-Afonso F., Siapati E.K., Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 2004, 117:5655-5664.
26. Niyibizi C., Li F. Potential implications of cell therapy for osteogenesis imperfecta. Int. J. Clin. Rheumatol. 2009, 4:57-66.
27. Panaroni C., Gioia R., Lupi A., Besio R., Goldstein S.A., Kreider J., et al. In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 2009, 114:459-468.
28. Chipman S.D., Sweet H.O., McBride D.J., Davisson M.T., Marks S.C., Shuldiner A.R., et al. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci U S A 1993, 90:1701-1705.
29. Phillips C.L., Bradley D.A., Schlotzhauer C.L., Bergfeld M., Libreros-Minotta C., Gawenis L.R., et al. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. Bone 2000, 27:219-226.
30. Song L., Young N.J., Webb N.E., Tuan R.S. Origin and characterization of multipotential mesenchymal stem cells derived from adult human trabecular bone. Stem Cells Dev 2005, 14:712-721.
31. Gambotto A., Dworacki G., Cicinnati V., Kenniston T., Steitz J., Tuting T., et al. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Ther 2000, 7:2036-2040.
32. Zitvogel L., Tahara H., Cai Q., Storkus W.J., Muller G., Wolf S.F., et al. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum Gene Ther 1994, 5:1493-1506.
33. Peng Z., Tuukkanen J., Zhang H., Jamsa T., Vaananen H.K. The mechanical strength of bone in different rat models of experimental osteoporosis. Bone 1994, 15:523-532.
34. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
35. Maddox J.R., Liao X., Li F., Niyibizi C. Effects of culturing on the stability of the putative murine adipose derived stem cells markers. Open Stem Cell J 2009, 1:54-61.
36. Shi M., Adachi Y., Shigematsu A., Koike-Kiriyama N., Feng W., Yanai S., et al. Intra-bone marrow injection of donor bone marrow cells suspended in collagen gel retains injected cells in bone marrow, resulting in rapid hemopoietic recovery in mice. Stem Cells 2008, 26:2211-2216.
37. Liao X., Li F., Wang X., Yanoso J., Niyibizi C. Distribution of murine adipose-derived mesenchymal stem cells in vivo following transplantation in developing mice. Stem Cells Dev 2008, 17:303-314.
38. Mason D.J., Hillam R.A., Skerry T.M. Constitutive in vivo mRNA expression by osteocytes of beta-actin, osteocalcin, connexin-43, IGF-I, c-fos and c-jun, but not TNF-alpha nor tartrate-resistant acid phosphatase. J Bone Miner Res 1996, 11:350-357.
39. Gnecchi M., He H., Melo L.G., Noiseaux N., Morello F., de Boer R.A., et al. Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 2009, 27:971-979.
40. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007, 213:341-347.
41. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
42. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005, 11:367-368.
43. Habibovic P., de Groot K. Osteoinductive biomaterials-properties and relevance in bone repair. J Tissue Eng Regen Med 2007, 1:25-32.
44. Novicoff W.M., Manaswi A., Hogan M.V., Brubaker S.M., Mihalko W.M., Saleh K.J. Critical analysis of the evidence for current technologies in bone-healing and repair. J Bone Joint Surg Am 2008, 90(Suppl 1):85-91.
45. Bi L.X., Simmons D.J., Mainous E. Expression of BMP-2 by rat bone marrow stromal cells in culture. Calcif Tissue Int 1999, 64:63-68.